Abstract
We examined the effects of the monoclonal antibody against the type I insulin-like growth factor receptor (IGF-IR), αIR3, on cell growth and membrane glutamine (Gln) transport in a human neuroblastoma cell line, SK-N-SH. In the presence of αIR3 (2 μg/ml), the cell proliferation rate was significantly attenuated. Gln transport was decreased in the αIR3-treated group with the mechanism of decreasing maximum transport velocity without affecting transport affinity. The addition of αIR3 significantly decreased DNA and protein biosynthesis. Our results support the concept that the activation of IGF-IR partially mediates neuroblastoma cell proliferation by regulating membrane Gln transport.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
